Alnylam Pharmaceuticals
Utility Patents
Last updated:
List of all Alnylam Pharmaceuticals patents 11 in total
| Status | Patent |
|---|---|
Grant | Utility: Modified RNAi agents Filling date: 6 Sep 2025 Issue date: 9 Aug 2022 |
Grant | Utility: Biodegradable lipids for the delivery of active agents Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Modified double-stranded RNA agents Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Biodegradable lipids for the delivery of active agents Filling date: 6 Sep 2025 Issue date: 12 Jul 2022 |
Grant | Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Filling date: 6 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Xanthine dehydrogenase (XDH) iRNA compositions and methods of use thereof Filling date: 6 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Methods for the treatment of subjects having a hepatitis b virus (HBV) infection Filling date: 6 Sep 2025 Issue date: 10 May 2022 |
Grant | Utility: Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Modified iRNA agents Filling date: 6 Sep 2025 Issue date: 26 Apr 2022 |
Grant | Utility: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases Filling date: 6 Sep 2025 Issue date: 29 Mar 2022 |
Showing 1 to 11 of 11 patents.